Bogado Pascottini O, Spricigo J F W, Van Schyndel S J, Mion B, Rousseau J, Weese J S, LeBlanc S J
Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
Department of Animal Biosciences, University of Guelph, Guelph, ON, Canada.
PLoS One. 2021 Feb 19;16(2):e0233943. doi: 10.1371/journal.pone.0233943. eCollection 2021.
This study evaluated the effects of treatment with meloxicam (a non-steroidal anti-inflammatory drug), parity, and blood progesterone concentration on the dynamics of the uterine microbiota of 16 clinically healthy postpartum dairy cows. Seven primiparous and 9 multiparous postpartum Holstein cows either received meloxicam (0.5 mg/kg SC, n = 7 cows) once daily for 4 days (10 to 13 days in milk (DIM)) or were untreated (n = 9 cows). Endometrial cytology samples were collected by cytobrush at 10, 21, and 35 DIM, from which the microbiota analysis was conducted using 16S rRNA gene sequence analysis. A radioimmunoassay was used to measure progesterone concentration in blood serum samples at 35 DIM and cows were classified as ˃ 1 ng/mL (n = 10) or ≤ 1 ng/mL (n = 6). Alpha diversity for bacterial genera (Chao1, Shannon-Weiner, and Camargo's evenness indices) were not affected by DIM, meloxicam treatment, parity, or progesterone category. For beta diversity (genera level), principal coordinate analysis (Bray-Curtis) showed differences in microbiota between parity groups. At the phylum level, the relative abundance of Actinobacteria was greater in primiparous than multiparous cows. At the genus level, there was lesser relative abundance of Bifidobacterium, Lactobacillus, Neisseriaceae, Paracoccus, Staphylococcus, and Streptococcus and greater relative abundance of Bacillus and Fusobacterium in primiparous than multiparous cows. Bray-Curtis dissimilarity did not differ by DIM at sampling, meloxicam treatment, or progesterone category at 35 DIM. In conclusion, uterine bacterial composition was not different at 10, 21, or 35 DIM, and meloxicam treatment or progesterone category did not affect the uterine microbiota in clinically healthy postpartum dairy cows. Primiparous cows presented a different composition of uterine bacteria than multiparous cows. The differences in microbiota associated with parity might be attributable to changes that occur consequent to the first calving, but this hypothesis should be investigated further.
本研究评估了美洛昔康(一种非甾体抗炎药)治疗、胎次和血液孕酮浓度对16头临床健康的产后奶牛子宫微生物群动态变化的影响。7头初产和9头经产的产后荷斯坦奶牛,要么在产奶第10至13天每天一次接受美洛昔康(0.5 mg/kg皮下注射,n = 7头奶牛),持续4天,要么不接受治疗(n = 9头奶牛)。在产奶第10、21和35天,通过细胞刷收集子宫内膜细胞学样本,并使用16S rRNA基因序列分析对其中的微生物群进行分析。采用放射免疫分析法测定产奶第35天血清样本中的孕酮浓度,并将奶牛分为˃1 ng/mL(n = 10)或≤1 ng/mL(n = 6)。细菌属的α多样性(Chao1、香农 - 韦纳和卡马戈均匀度指数)不受产奶天数、美洛昔康治疗、胎次或孕酮类别影响。对于β多样性(属水平),主坐标分析(Bray - Curtis)显示胎次组之间微生物群存在差异。在门水平上,初产奶牛中放线菌的相对丰度高于经产奶牛。在属水平上,初产奶牛中双歧杆菌、乳酸杆菌、奈瑟菌科、副球菌、葡萄球菌和链球菌的相对丰度低于经产奶牛,而芽孢杆菌和梭杆菌的相对丰度高于经产奶牛。在采样时,Bray - Curtis差异在产奶天数、美洛昔康治疗或产奶第35天的孕酮类别方面没有差异。总之,在产奶第10、21或35天,子宫细菌组成没有差异,美洛昔康治疗或孕酮类别对临床健康的产后奶牛子宫微生物群没有影响。初产奶牛的子宫细菌组成与经产奶牛不同。与胎次相关的微生物群差异可能归因于首次产犊后发生的变化,但这一假设应进一步研究。